Financhill
Back

ChemoCentryx 10K Form

Buy
59

CCXI
ChemoCentryx

Last Price:
50.85
Seasonality Move:
7.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CCXI News And Ratings

See the #1 stock for the next 7 days that we like better than CCXI

CCXI Financial Statistics

Sales & Book Value

Annual Sales: $31.9M
Cash Flow: $-26.53M
Price / Cash Flow: 0
Annual Sales: $3.32
Price / Book: 15.34

Profitability

EPS (TTM): -1.89000
Net Income (TTM): $-133.09M
Gross Margin: $31.6M
Return on Equity: -46.62%
Return on Assets: -30.14%

ChemoCentryx Earnings Forecast

Key ChemoCentryx Financial Ratios

  • The Gross Profit Margin over the past 11 years for CCXI is 99.06%.
  • The Selling, General & Administrative Expenses for CCXI have been equal to 247.18% of Gross Profit Margin.
  • The Research & Development expenses have been 260.16% of Revenue.
  • The Interest Expense is -2.05% of Operating Income.
  • The Net Earning history of CCXI is -413.04% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 5 years.

ChemoCentryx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: CCXI
CUSIP: 16383L
Website: chemocentryx.com

Debt

Debt-to-Equity Ratio: 0.1
Current Ratio: 4.54
Quick Ratio: 4.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CCXI Technical Analysis vs Fundamental Analysis

Buy
59
ChemoCentryx (CCXI) is a Buy

Is ChemoCentryx a Buy or a Sell?

  • ChemoCentryx stock is rated a Buy
    The current ChemoCentryx [CCXI] share price is $50.86. The Score for CCXI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.